---
title: "Doxepin - Atopic Dermatitis"
sidebar: mydoc_sidebar
permalink: db01142-mesh-d003876-1.html
toc: false 
---


Path ID: `DB01142_MESH_D003876_1`
{% include image.html url="images/db01142-mesh-d003876-1.png" file="db01142-mesh-d003876-1.png" alt="db01142-mesh-d003876-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D004316">MESH:D004316 </a> | doxepin | Drug |
| <a href="https://identifiers.org/UniProt:P35367">UniProt:P35367 </a> | Histamine H1 receptor | Protein |
| <a href="https://identifiers.org/UniProt:P25021">UniProt:P25021 </a> | Histamine H2 receptor | Protein |
| <a href="https://identifiers.org/GO:0004969">GO:0004969 </a> | Histamine receptor activity | MolecularActivity |
| <a href="https://identifiers.org/GO:0071420">GO:0071420 </a> | Cellular response to histamine | BiologicalProcess |
| <a href="https://identifiers.org/GO:0006954">GO:0006954 </a> | Inflammatory response | BiologicalProcess |
| <a href="https://identifiers.org/HP:0000989">HP:0000989 </a> | Pruritus | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D003876">MESH:D003876 </a> | Atopic dermatitis | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Doxepin | DECREASES ACTIVITY OF | Histamine H1 Receptor |
| Doxepin | DECREASES ACTIVITY OF | Histamine H2 Receptor |
| Histamine H1 Receptor | POSITIVELY REGULATES | Histamine Receptor Activity |
| Histamine H2 Receptor | POSITIVELY REGULATES | Histamine Receptor Activity |
| Histamine Receptor Activity | PARTICIPATES IN | Cellular Response To Histamine |
| Cellular Response To Histamine | POSITIVELY CORRELATED WITH | Inflammatory Response |
| Inflammatory Response | POSITIVELY CORRELATED WITH | Pruritus |
| Pruritus | MANIFESTATION OF | Atopic Dermatitis |
|---------|-----------|---------|

Comment: Topical doxepin is approved for short-term (up to 8 days) management of moderate pruritus in adult patients with atopic dermatitis, pruritus or lichen simplex chronicus. Antihistamine properties of doxepin is beleived to be MoA

Reference: 
  - [https://go.drugbank.com/drugs/DB01142](https://go.drugbank.com/drugs/DB01142)
  - [https://en.wikipedia.org/wiki/Doxepin](https://en.wikipedia.org/wiki/Doxepin)
  - [https://pubmed.ncbi.nlm.nih.gov/9161661/](https://pubmed.ncbi.nlm.nih.gov/9161661/)
  - [https://pubmed.ncbi.nlm.nih.gov/8089287/](https://pubmed.ncbi.nlm.nih.gov/8089287/)
